Key result
Homozygosity for a risk haplotype at the adiponectin locus was associated with higher body weight and multiple components of the insulin resistance syndrome in Caucasians.
Why the study?
Is a haplotype at the adiponectin locus associated with obesity and features of the insulin resistance syndrome in Caucasians?
Observational (n=1,027)
Is a haplotype at the adiponectin locus associated with obesity and features of the insulin resistance syndrome in Caucasians?
A specific haplotype at the adiponectin locus is associated with obesity and multiple features of the insulin resistance syndrome in Caucasians, likely acting as a marker for an unidentified functional polymorphism.
Answers are grounded in this paper and cite their sources.
No immediate clinical change from this association; leaves open causal role of adiponectin haplotype pending prospective validation.
Adiponectin is a protein secreted by adipocytes that modulates insulin action. To assess whether variants of this gene contribute to the prevalence of insulin resistance in Caucasians, we genotyped 413 nondiabetic individuals for two single nucleotide polymorphisms (SNPs) at this locus. The two SNPs (45T-->G and 276G-->T) were chosen because of their association with type 2 diabetes in Japanese. Whereas each polymorphism was significantly associated with some correlate of insulin resistance, the haplotype defined by the two together was strongly associated with many components of the insulin resistance syndrome. Homozygotes for the risk haplotype had higher body weight (P = 0.03), waist circumference (P = 0.004), systolic (P = 0.01) and diastolic (P = 0.003) blood pressure, fasting glucose (P = 0.02) and insulin (P = 0.005) levels, homeostasis model assessment (HOMA) for insulin resistance (P = 0.003), and total to HDL cholesterol ratio (P = 0.01). Homozygotes also had significantly lower plasma levels of adiponectin (P = 0.03), independent of sex, age, and body weight. In an independent study group of 614 Caucasians, including 310 with type 2 diabetes, the risk haplotype was confirmed to be associated with increased body weight (P = 0.03) but not with type 2 diabetes per se. We conclude that variability at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome, but given the nature of the two SNPs, the risk haplotype is most probably a marker in linkage disequilibrium with an as yet unidentified polymorphism that affects plasma adiponectin levels and insulin sensitivity.
No takes yet. Share an insight, caveat, or question.
Menzaghi et al. (2002) conducted an observational in Insulin resistance syndrome and obesity (n=1,027). Adiponectin locus risk haplotype (45T-->G and 276G-->T) vs. Non-homozygotes / non-risk haplotype was evaluated on Components of the insulin resistance syndrome (body weight, waist circumference, blood pressure, fasting glucose, insulin, HOMA, and lipid ratios). Homozygosity for a risk haplotype at the adiponectin locus was associated with higher body weight and multiple components of the insulin resistance syndrome in Caucasians.
Synapse has enriched 10 related papers. Consider them for comparative context: